ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
127 hedge funds and large institutions have $418M invested in Intra-Cellular Therapies Inc. in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 42 increasing their positions, 46 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
49% less capital invested
Capital invested by funds: $827M → $418M (-$409M)
Holders
127
Holding in Top 10
–
Calls
$49.3M
Puts
$11.8M
Top Buyers
| 1 | +$5.64M | |
| 2 | +$4.35M | |
| 3 | +$3.42M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.07M |
| 5 |
Two Sigma Investments
New York
|
+$2.19M |
Top Sellers
| 1 | -$11M | |
| 2 | -$6.45M | |
| 3 | -$4.24M | |
| 4 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$4.18M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$4.07M |